Körber certifies eschbach’s Shiftconnector platform for enhanced shopfloor collaboration using PAS-X MES data: Lüneburg, Germany Wednesday, March 19, 2025, 17:00 Hrs [IST] Kö ...

By integrating PAS-X MES data with Shiftconnector, we're unlocking new levels of transparency and efficiency. This collaboration enables pharma and biopharma enterprises to make faster ...

Morningstar brands and products Company Portfolio ...

HightByte’s PAS-X MES will integrate as part of the Körber Ecosystem Partner Program for improved data visibility and ...

Aspire Biopharma Holdings, Inc. ("Aspire Biopharma") is scheduled to begin trading on Nasdaq on February 20, 2025 under the ticker symbol "ASBP". HUMACO, PR AND NEW YORK, NY / ACCESS Newswire ...

This brings an inflection point in the biopharma sector, by forging a sustainable pathway for the industry to cater to India’s collective aim of a 45% reduction in emission intensity by 2030 and ...

Aspire Biopharma (ASBP), a developer of a drug delivery mechanism technology, and PowerUp Acquisition Corp. (PWUP), a Nasdaq Global Market listed special purpose acquisition company, announced the ...

AI and IoT are standard in many industries but not, it seems, in biopharma. A recent paper notes that between 2019 and 2023, only about 19% of the biopharma papers reviewed mentioned AI.

IRVINE, Calif., Feb. 24, 2025 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (NYSE: AEON) (the “Company”), a clinical-stage biopharmaceutical company focused on developing a botulinum toxin complex ...

CHICAGO--(BUSINESS WIRE)--Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a fast-growing biopharmaceutical company committed to improving patient lives by developing and commercializing innovative ...

NEW YORK CITY, NY / ACCESS Newswire / February 20, 2025 / Aspire Biopharma, Inc. ("Aspire" or the "Company"), a developer of a multi-faceted patent-protected disruptive drug delivery mechanism ...